Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Product revenue, net $ 18,925,000 $ 17,025,000 $ 52,685,000 $ 45,173,000
Other revenue 42,000 606,000 753,000 606,000
Total revenue 18,967,000 17,631,000 53,438,000 45,779,000
Operating expenses        
Cost of goods sold - (excluding amortization of acquired intangible assets) 5,884,000 5,755,000 18,245,000 15,484,000
Amortization of acquired intangible assets 969,000 1,064,000 3,064,000 3,193,000
Research and development 51,000 287,000 105,000 326,000
Selling, general and administrative 12,593,000 12,054,000 33,590,000 34,505,000
Total operating expenses 19,497,000 19,160,000 55,004,000 53,508,000
Loss from operations (530,000) (1,529,000) (1,566,000) (7,729,000)
Other expense (income)        
Interest income (140,000) (154,000) (451,000) (441,000)
Interest expense 919,000 937,000 2,717,000 2,765,000
Foreign exchange transaction losses 6,000 3,000 10,000 71,000
Total other expense 785,000 786,000 2,276,000 2,395,000
Loss before income taxes (1,315,000) (2,315,000) (3,842,000) (10,124,000)
Income tax expense 0   15,000 60,000
Net loss $ (1,315,000) $ (2,315,000) $ (3,857,000) $ (10,184,000)
Net loss per common share:        
Basic (In dollars per share) $ (0.05) $ (0.09) $ (0.14) $ (0.43)
Diluted (In dollars per share) $ (0.05) $ (0.09) $ (0.14) $ (0.43)
Weighted average number of common shares:        
Basic (In shares) 28,069,125 24,959,114 27,625,414 23,628,921
Diluted (In shares) 28,069,125 24,959,114 27,625,414 23,628,921